Cargando…

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia

Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS v...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Juan, Tu, Sha, Lin, Guoxin, Guo, Hui, Yan, Chengkai, Liu, Qingjun, Huang, Ling, Tang, Na, Xiao, Yizhi, Pope, R. Marshall, Rajaram, Murugesan V.S., Amer, Amal O., Ahmer, Brian M., Gunn, John S., Wozniak, Daniel J., Tao, Lijian, Coppola, Vincenzo, Zhang, Liwen, Langdon, Wallace Y., Torrelles, Jordi B., Lipkowitz, Stanley, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144527/
https://www.ncbi.nlm.nih.gov/pubmed/31999304
http://dx.doi.org/10.1084/jem.20182091
_version_ 1783519851478777856
author Tang, Juan
Tu, Sha
Lin, Guoxin
Guo, Hui
Yan, Chengkai
Liu, Qingjun
Huang, Ling
Tang, Na
Xiao, Yizhi
Pope, R. Marshall
Rajaram, Murugesan V.S.
Amer, Amal O.
Ahmer, Brian M.
Gunn, John S.
Wozniak, Daniel J.
Tao, Lijian
Coppola, Vincenzo
Zhang, Liwen
Langdon, Wallace Y.
Torrelles, Jordi B.
Lipkowitz, Stanley
Zhang, Jian
author_facet Tang, Juan
Tu, Sha
Lin, Guoxin
Guo, Hui
Yan, Chengkai
Liu, Qingjun
Huang, Ling
Tang, Na
Xiao, Yizhi
Pope, R. Marshall
Rajaram, Murugesan V.S.
Amer, Amal O.
Ahmer, Brian M.
Gunn, John S.
Wozniak, Daniel J.
Tao, Lijian
Coppola, Vincenzo
Zhang, Liwen
Langdon, Wallace Y.
Torrelles, Jordi B.
Lipkowitz, Stanley
Zhang, Jian
author_sort Tang, Juan
collection PubMed
description Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS via a caspase-11/NLRP3–dependent manner. Further studies show that NLRP3 undergoes both K63- and K48-linked polyubiquitination. Cbl-b binds to the K63-ubiquitin chains attached to the NLRP3 leucine-rich repeat domain (LRR) via its ubiquitin-associated region (UBA) and then targets NLRP3 at K496 for K48-linked ubiquitination and proteasome-mediated degradation. We also identify RNF125 as an additional E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 LRR domain. Therefore, NLRP3 is sequentially ubiquitinated by K63- and K48-linked ubiquitination, thus keeping the NLRP3 inflammasomes in check and restraining endotoxemia.
format Online
Article
Text
id pubmed-7144527
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-71445272020-10-06 Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia Tang, Juan Tu, Sha Lin, Guoxin Guo, Hui Yan, Chengkai Liu, Qingjun Huang, Ling Tang, Na Xiao, Yizhi Pope, R. Marshall Rajaram, Murugesan V.S. Amer, Amal O. Ahmer, Brian M. Gunn, John S. Wozniak, Daniel J. Tao, Lijian Coppola, Vincenzo Zhang, Liwen Langdon, Wallace Y. Torrelles, Jordi B. Lipkowitz, Stanley Zhang, Jian J Exp Med Article Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS via a caspase-11/NLRP3–dependent manner. Further studies show that NLRP3 undergoes both K63- and K48-linked polyubiquitination. Cbl-b binds to the K63-ubiquitin chains attached to the NLRP3 leucine-rich repeat domain (LRR) via its ubiquitin-associated region (UBA) and then targets NLRP3 at K496 for K48-linked ubiquitination and proteasome-mediated degradation. We also identify RNF125 as an additional E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 LRR domain. Therefore, NLRP3 is sequentially ubiquitinated by K63- and K48-linked ubiquitination, thus keeping the NLRP3 inflammasomes in check and restraining endotoxemia. Rockefeller University Press 2020-01-30 /pmc/articles/PMC7144527/ /pubmed/31999304 http://dx.doi.org/10.1084/jem.20182091 Text en © 2020 Tang et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Tang, Juan
Tu, Sha
Lin, Guoxin
Guo, Hui
Yan, Chengkai
Liu, Qingjun
Huang, Ling
Tang, Na
Xiao, Yizhi
Pope, R. Marshall
Rajaram, Murugesan V.S.
Amer, Amal O.
Ahmer, Brian M.
Gunn, John S.
Wozniak, Daniel J.
Tao, Lijian
Coppola, Vincenzo
Zhang, Liwen
Langdon, Wallace Y.
Torrelles, Jordi B.
Lipkowitz, Stanley
Zhang, Jian
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title_full Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title_fullStr Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title_full_unstemmed Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title_short Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
title_sort sequential ubiquitination of nlrp3 by rnf125 and cbl-b limits inflammasome activation and endotoxemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144527/
https://www.ncbi.nlm.nih.gov/pubmed/31999304
http://dx.doi.org/10.1084/jem.20182091
work_keys_str_mv AT tangjuan sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT tusha sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT linguoxin sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT guohui sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT yanchengkai sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT liuqingjun sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT huangling sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT tangna sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT xiaoyizhi sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT popermarshall sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT rajarammurugesanvs sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT ameramalo sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT ahmerbrianm sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT gunnjohns sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT wozniakdanielj sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT taolijian sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT coppolavincenzo sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT zhangliwen sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT langdonwallacey sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT torrellesjordib sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT lipkowitzstanley sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia
AT zhangjian sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia